Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Phosphate in blood, psychotropic effects
Physical monitoring Carbamazepine Lithium Valproate
Physiological risk factors
Physiological risk factors for QTc prolongation and arrhythmia
Pilosinart Hepatic impairment Psychotropics in overdose Renal impairment
Pimavanserin Antipsychotics - minimum effective doses Equivalent doses psychiatric adverse effects of treatments Quick reference for licensed maximum doses Switching antipsychotics
Placebo and nocebo effects, patient expectations of treatment
Plasma drug levels, elevated due to reduced hepatic blood flow
Plasma glucose levels, antipsychotic medication monitoring
Plasma level monitoring Acting on clozapine plasma concentration results Plasma level monitoring of psychotropic drugs
Plasma level monitoring of psychotropic drugs amisulpride aripiprazole clozapine first-order pharmacokinetics gender effects olanzapine Plasma level monitoring of psychotropic drugs quetiapine risperidone sampling time steady state target ranges
Plasma levels
Plasma level variations
Plasma lipids
Plasma lipids, effect on
Plasma protein synthesis reduction, hepatic impairment
Platelets agents associated with aggregation psychotropic agent effects
Plecanatide, for constipation treatment
Pneumonien, antipsychotic-induced Clozapine: common adverse effects Pneumonia
Polycystic ovaries
Polypharmacy adverse effects Alternatives to clozapine Antipsychotic response - to increase the dose, to switch, to add or just wait - what is the right move? Combined antipsychotics (antipsychotic polypharmacy) long-term treatment Paliperidone palmitate long-acting injection poor response to antipsychotic monotherapy
Polypharmacy, menopausal women
Polysubstance abuse
Polysubstance abuse, opioids plus cocaine
Poor tolerability
PORT see Program of Rehabilitation and Therapy
Possible causes of psychiatric symptoms in people with epilepsy (PWE) and their management
Possible risks in pregnancy
post-injection delirium sedation syndrome (PDSS) 76 Antipsychotic depots/long-acting injections Olanzapine long-acting injection
post menopause, continuous combined HRT